Sensorineural hearing loss in patients with cystic fibrosis

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 1, 2009, Pages 86-90

  Cheng, Alan G ^a,b   Johnston, Patrick R ^a   Luz, Jennifer ^a   Uluer, Ahmet ^a   Fligor, Brian ^a   Licameli, Greg R ^a,b   Kenna, Margaret A ^a,b   Jones, Dwight T ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; MACROLIDE;

ADOLESCENT; ARTICLE; AUDIOGRAPHY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; DEMOGRAPHY; FEMALE; GENOTYPE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PERCEPTION DEAFNESS; PREVALENCE; SCHOOL CHILD; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AMINOGLYCOSIDES; AUDIOMETRY; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; INCIDENCE; INFANT; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE;

EID: 67549100932     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.03.020     Document Type: Article

References (20)

1. Brummett R.E. Drug-induced ototoxicity. Drugs 19 (1980) 412-428
2. Piltcher O.B., Teixeira V.N., de Oliveira M.W., et al. The prevalence of neurosensorial hearing loss among cystic fibrosis patients from Hospital de Clinicas de Porto Alegre. Int J Pediatr Otorhinolaryngol 67 (2003) 939-941
3. Stavroulaki P., Vossinakis I.C., Dinopoulou D., et al. Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis. Arch Otolaryngol Head Neck Surg 128 (2002) 150-155
4. Contopoulos-Ioannidis D.G., Giotis N.D., Baliatsa D.V., et al. Extended-interval aminoglycoside administration for children: a meta-analysis. Pediatrics 114 (2004) e11118
5. Mulherin D., Fahy J., Grant W., et al. Aminoglycoside induced ototoxicity in patients with cystic fibrosis. Ir J Med Sci 160 (1991) 173-175
6. Mulheran M., Degg C., Burr S., et al. Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy. Antimicrob Agents Chomother 45 (2001) 2502-2509
7. Forman-Franco B., Abramson A.L., Gorvoy J.D., et al. Cystic fibrosis and hearing loss. Arch Otolaryngol 105 (1979) 338-342
8. Katbamna B., Homnick D.N., and Marks J.H. Effects of chronic tobramycin treatment on distortion product otoacoustic emissions. Ear Hear 20 (1999) 393-402
9. Crifo S., Antonelli M., Gagliardi M., et al. Ototoxicity of aminoglucoside antibiotics in long-term treatment for cystic fibrosis. Int J Pediatr Otorhinolaryngol 2 (1980) 251-253
10. McRorie T.I., Bosso J., and Randolph L. Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry. Am J Dis Child 143 (1989) 1328-1332
11. Ichimiya T., Takeoka K., Hiramatsu K., et al. The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. Chemotherapy 42 (1996) 186-191
12. Mamikoglu B., and Mamikoglu O. Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report. Ann Otol Rhinol Laryngol 110 (2001) 102
13. Ress B.D., and Gross E.M. Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report. Ann Otol Rhinol Laryngol 109 (2000) 435-437
14. Northern J.L., and Downs M.P. Hearing in children. 4th ed. (1991), Williams & Wilkins, Baltimore
15. Cheng A.G., Cunningham L.L., and Rubel E.W. Mechanisms of hair cell death and protection. Curr Opin Otolaryngol Head Neck Surg 13 (2005) 343-348
16. Whatley W.S., Chandra R.K., and MacDonald C.B. Systemic absorption of gentamicin nasal irrigations. Am J Rhinol 20 (2006) 251-254
17. Cheer S.N., Waugh J., and Noble S. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. Drugs 63 (2003) 2501-2520
18. Patatanian L. Inhaled tobramycin-associated hearing loss in an adolescent with renal failure. Pediatr Infect Dis J 25 (2006) 276-278
19. López-Boado Y.S., and Rubin B.K. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Curr Opin Pharmacol 8 (2008) 286-291
20. Mulheran M., and Degg C. Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects. Br J Audiol 31 (1997) 5-9